ITEMS IN AFP WITH KEYWORD:
Mar 1, 2010 Issue
Addition of Long-Acting Beta Agonists for Asthma in Children [Cochrane for Clinicians]
In children with persistent asthma who are already taking inhaled corticosteroids, the addition of a LABA does not lower the rate of exacerbations requiring oral steroids, rescue medication, or hospitalizations, but it improves measurable lung function.
Jun 1, 2009 Issue
Should Salmeterol Be Used for Long-Term Asthma Control? [Cochrane for Clinicians]
Salmeterol may help improve asthma symptoms, but it should only be used as part of a comprehensive asthma management plan including inhaled corticosteroids and a short-acting beta agonist. There is currently insufficient evidence to confirm that salmeterol does not increase the risk of adverse event...
The Expert Panel Report 3 of the National Asthma Education and Prevention Program represents a major advance in the approach to asthma care by emphasizing the monitoring of clinically relevant aspects of care and the importance of planned primary care, and by providing patients practical tools for s...
Can patients with mild persistent asthma safely decrease or eliminate inhaled steroids? The results of these studies may not be generalizable to the average primary care patient. Patients should be appropriately classified and treated using 2007 National Asthma Education and Prevention Program guidelines.
May 1, 2008 Issue
Albuterol vs. Levalbuterol for Asthma Treatment in Children [AFP Journal Club]
For children with acute asthma exacerbations, is levalbuterol better than albuterol? There is no difference between the medications in effectiveness or side effects.
Wheezing in children is a common problem encountered by family physicians. Approximately 25 to 30 percent of infants will have at least one wheezing episode, and nearly one half of children have a history of wheezing by six years of age. The most common causes of wheezing in children include asthma,...
Levalbuterol tartrate appears to be no more effective and offers no improvement in the side-effect profile compared with albuterol. The higher cost may make it appropriate for only a limited group of patients.
Leukotriene inhibitors are the first new class of medications for the treatment of persistent asthma that have been approved by the U.S. Food and Drug Administration in more than two decades. They also have been approved for the treatment of allergic rhinitis. Prescriptions of leukotriene inhibitors...
What are the effects of treatments for acute asthma in children? What is the effect of single-agent prophylaxis in children taking inhaled beta agonists as needed for asthma?What are the effects of additional prophylactic treatments in patients with childhood asthma that is inadequately controlled b...